Biofrontera Inc.

NASDAQ: BFRI · Real-Time Price · USD
0.93
-0.04 (-3.73%)
At close: Aug 15, 2025, 11:52 AM

Biofrontera Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.76M -20.13M -640K -37.71M
Depreciation & Amortization
1.15M 1.06M 1.17M 540K
Stock-Based Compensation
1.02M 1.04M 1.85M 129K
Other Working Capital
4.1M -11.99M 4.76M 8.68M
Other Non-Cash Items
-891K -2.48M -21.37M -1.04M
Deferred Income Tax
n/a n/a n/a 12.88M
Change in Working Capital
6.21M -4.39M 2.79M -1.5M
Operating Cash Flow
-10.27M -24.89M -16.2M -26.71M
Capital Expenditures
-10K -5K -38K -11K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -5.12M n/a
Sales Maturities Of Investments
57K 624K n/a n/a
Other Investing Acitivies
-50K n/a n/a n/a
Investing Cash Flow
-3K 619K -5.16M -11K
Debt Repayment
-265K 3.9M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7.44M n/a 4.63M 13.25M
Financial Cash Flow
14.84M 8.41M 14.02M 43.19M
Net Cash Flow
4.56M -15.87M -7.33M 16.46M
Free Cash Flow
-10.28M -24.9M -16.24M -26.73M